Alan Tenenbaum concentrates his practice on commercial and intellectual property litigation and counseling. He represents corporate clients throughout the United States and before the International Trade Commission in litigation involving patent, trademark, unfair competition, and commercial claims. Alan’s litigation and trial work include matters involving electronic hardware, software, consumer products, medical devices, chemicals, and both branded and generic pharmaceuticals. He also represents clients in disputes involving the importation and transportation of goods and claims against customs agents and freight brokers.
Alan is a trusted general counsel to a variety of companies. Applying business solutions from a legal perspective, he works with clients to identify, acquire, protect, manage, and monetize products, technology, and intellectual property rights.
Alan advises clients who seek to manage, avoid, and resolve commercial disputes, with and without recourse to litigation, and has litigated and resolved a variety of matters involving nuisance patents and patent assertion entities.
In addition, Alan negotiates IP and IT agreements and other complex commercial agreements involving technology. He has a successful track record in the prosecution of patent applications involving software-implemented applications.
Alan frequently speaks and writes on the topics of patent litigation, software patents, and the business and legal issues associated with emerging technology. He has been named in New York Super Lawyers® for many years, most recently in 2021. A description of the selection methodology can be found here. He is also AV Preeminent® rated by Martindale-Hubbell.
Alan Tenenbaum was selected to the 2013 – 2017, 2020 – 2021 Super Lawyers® lists. The Super Lawyers List is issued by Thompson Reuters. A description of the selection methodology can be found here.
Alan Tenenbaum has earned the Martindale-Hubbell AV Preeminent® status. A description of the selection methodology can be found here.